Chen Shen
About
In The Last Decade
Chen Shen
23 papers receiving 287 citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Molecular Biology 136
- Epidemiology 47
- Hepatology 47
- Biomedical Engineering 43
- Oncology 39
Countries citing papers authored by Chen Shen
This map shows the geographic impact of Chen Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Shen more than expected).
Fields of papers citing papers by Chen Shen
This network shows the impact of papers produced by Chen Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Shen. The network helps show where Chen Shen may publish in the future.
Co-authorship network of co-authors of Chen Shen
This figure shows the co-authorship network connecting the top 25 collaborators of Chen Shen. A scholar is included among the top collaborators of Chen Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen Shen. Chen Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 16 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 0 | |
| 9 | 1 | |
| 10 | 23 | |
| 11 | 1 | |
| 12 | 17 | |
| 13 | 3 | |
| 14 | Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances breakdown → | 84 |
| 15 | 5 | |
| 16 | 1 | |
| 17 | 6 | |
| 18 | 13 | |
| 19 | 6 | |
| 20 | Glycyrrhizin improves inflammation and apoptosis via suppressing HMGB1 and PI3K/mTOR pathway in lipopolysaccharide-induced acute liver injury | 13 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.